Sign in

CIK 0001721484

  • Emerging growth company

Longeveron Inc.

Sign in to watch
Ticker
LGVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472174146
Phone
+1 305-302-7158
Business address
1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
Former names
LONGEVERON LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 14 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-09-20 Lehr Paul T General Counsel, Secretary Option exercise · Subscription Rights (right to buy) −2,000 729,625
2023-09-12 Hare Joshua Chief Scientific Officer Option exercise +30,000 $3.00 $90K 7,823,263
2023-09-12 Hare Joshua Chief Scientific Officer Option exercise · Subscription Rights (right to buy) −30,000 39,196,771
2023-09-12 Locklear Lisa Chief Financial Officer Other acquisition +5,000 $3.00 $15K 45,000
2023-09-12 Locklear Lisa Chief Financial Officer Purchase · Subscription Rights (right to buy) +5,000 $0.02 $75 5,000
2023-09-12 Locklear Lisa Chief Financial Officer Other disposition · Subscription Rights (right to buy) −5,000 0
2023-09-12 Hashad Mohamed Wa'el Ahmed Chief Executive Officer Option exercise +10,000 $3.00 $30K 47,566
2023-09-12 Hashad Mohamed Wa'el Ahmed Chief Executive Officer Option exercise · Subscription Rights (right to buy) −10,000 95,905
2023-09-12 Hashad Mohamed Wa'el Ahmed Chief Executive Officer Sale · Subscription Rights (right to buy) −100 $0.02 $2 95,805
2023-09-12 Hashad Mohamed Wa'el Ahmed Chief Executive Officer Sale · Subscription Rights (right to buy) −100 $0.02 $2 95,705
2023-09-12 Hashad Mohamed Wa'el Ahmed Chief Executive Officer Sale · Subscription Rights (right to buy) −253 $0.02 $4 95,452
2023-09-12 Hashad Mohamed Wa'el Ahmed Chief Executive Officer Sale · Subscription Rights (right to buy) −400 $0.02 $8 95,052
2023-09-12 Hashad Mohamed Wa'el Ahmed Chief Executive Officer Sale · Subscription Rights (right to buy) −2,852 $0.02 $47 92,200
2023-09-12 Hashad Mohamed Wa'el Ahmed Chief Executive Officer Sale · Subscription Rights (right to buy) −3,000 $0.02 $48 89,200
2023-09-12 Hashad Mohamed Wa'el Ahmed Chief Executive Officer Sale · Subscription Rights (right to buy) −6,700 $0.02 $109 82,500
2023-09-08 Hare Joshua Chief Scientific Officer Sale · Subscription Rights (right to buy) −50,000 $0.02 $885 39,226,771
2023-09-08 Soffer Rock Director Option exercise +30,000 $3.00 $90K 702,351
2023-09-08 Soffer Rock Director Option exercise · Subscription Rights (right to buy) −30,000 3,329,255
2023-09-07 Hare Joshua Chief Scientific Officer Sale · Subscription Rights (right to buy) −15,400 $0.02 $370 39,276,771
2023-09-06 Hare Joshua Chief Scientific Officer Sale · Subscription Rights (right to buy) −17,700 $0.03 $453 39,292,171

Page 9 of 14 · 271 trades